NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

A. F. Herrera; M. LeBlanc; S. M. Castellino; H. Li; S. C. Rutherford; A. M. Evens; K. Davison; A. Punnett; D. Hodgson; S. K. Parsons; S. Ahmed; C. Casulo; N. L. Bartlett; J. M. Tuscano; M. G. Mei; B. T. Hess; R. Jacobs; H. Saeed; P. Torka; B. Hu; C. Moskowitz; S. Kaur; G. Goyal; C. Forlenza; A. Doan; A. Lamble; P. Kumar; S. Chowdhury; B. Brinker; N. Sharma; A. Singh; K. Blum; A. M. Perry; A. Kovach; L. S. Constine; L. Kostakoglu Shields; A. Prica; R. F. Little; M. A. Shipp; M. Crump; B. Kahl; J. P. Leonard; S. M. Smith; J. Y. Song; K. M. Kelly; J. W. Friedberg

doi:10.1002/hon.3163_5

Back

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Journal article

Peer reviewed

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

A. F. Herrera, M. LeBlanc, S. M. Castellino, H. Li, S. C. Rutherford, A. M. Evens, K. Davison, A. Punnett, D. Hodgson, S. K. Parsons, …

Hematological oncology, Vol.41(S2), pp.33-35

2023-06

DOI: https://doi.org/10.1002/hon.3163_5

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

See more details

Details

Title: NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826
Creators: A. F. Herrera - City of Hope
M. LeBlanc - Data Management Services
S. M. Castellino - Children's Healthcare of Atlanta
H. Li - Data Management Services
S. C. Rutherford - Cornell College
A. M. Evens - Rutgers University
K. Davison - McGill University Health Centre
A. Punnett - SickKids Foundation
D. Hodgson - Princess Margaret Cancer Centre
S. K. Parsons - Tufts Medical Center
S. Ahmed - The University of Texas MD Anderson Cancer Center
C. Casulo - University of Rochester
N. L. Bartlett - Washington University in St. Louis
J. M. Tuscano - University of California, Davis
M. G. Mei - City Of Hope National Medical Center
B. T. Hess - Medical University of South Carolina
R. Jacobs - Carolinas Medical Center
H. Saeed - Moffitt Cancer Center
P. Torka - Memorial Sloan Kettering Cancer Center
B. Hu - Huntsman Cancer Institute
C. Moskowitz - Sylvester Comprehensive Cancer Center
S. Kaur - The University of Texas at San Antonio
G. Goyal - University of Alabama at Birmingham
C. Forlenza - Memorial Sloan Kettering Cancer Center
A. Doan - Children's Hospital of Los Angeles
A. Lamble - Seattle Children's Hospital
P. Kumar - Illinois CancerCare
S. Chowdhury - Prisma Health
B. Brinker - West Michigan Cancer Center
N. Sharma - Community Medical Center
A. Singh - Fairview Ridges Hospital
K. Blum - Emory University Hospital
A. M. Perry - Michigan United
A. Kovach - Children's Hospital of Los Angeles
L. S. Constine - University of Rochester
L. Kostakoglu Shields - University of Virginia
A. Prica - Princess Margaret Cancer Centre
R. F. Little - National Cancer Institute
M. A. Shipp - Dana–Farber Cancer Institute
M. Crump - Princess Margaret Cancer Centre
B. Kahl - Washington University in St. Louis
J. P. Leonard - Cornell College
S. M. Smith - University of Chicago
J. Y. Song - City Of Hope National Medical Center
K. M. Kelly - Roswell Park Cancer Institute
J. W. Friedberg - University of Rochester
Publication Details: Hematological oncology, Vol.41(S2), pp.33-35
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031821235802976